| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 7 | |
| #2 | WIPO (World Intellectual Property Organization) | 2 | |
| #3 | Australia | 1 | |
| #4 | Brazil | 1 | |
| #5 | China | 1 | |
| #6 | EPO (European Patent Office) | 1 | |
| #7 | Israel | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Foods and drinks |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Peptides | |
| #3 | Enzymes | |
| #4 | Microorganisms | |
| #5 | Therapeutic chemical compounds | |
| #6 | Fermentation |
| # | Name | Total Patents |
|---|---|---|
| #1 | Fuchs Tobias A | 11 |
| #2 | Englert Hanna | 9 |
| #3 | Jiménez-Alcázar Miguel | 7 |
| #4 | Göbel Josephine | 4 |
| #5 | Fuchs Tobias | 3 |
| #6 | Hakkim R Abdul | 2 |
| #7 | Göbel Josephine (Formerly Bitterling | 2 |
| #8 | Miguel Jiménez-Alcázar | 1 |
| #9 | Hakkim R | 1 |
| #10 | Jimenez-Alcazar Miguel | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2020323917A1 | Dnase1-like 3 and its use in therapy | |
| WO2020163264A1 | Engineered human extracellular dnase enzymes for drug candidate selection | |
| US2020115690A1 | Manufacturing and engineering of DNASE enzymes for therapy | |
| WO2020076817A1 | Engineering of dnase enzymes for manufacturing and therapy | |
| EP3668972A2 | Engineered dnase enzymes and use in therapy |